Eton Pharmaceuticals News and Activities

Eton Pharmaceuticals is a company listed under the stock ticker ETON (US).

View the org chart displaying its 19 main executives

Most searched biographies at Eton Pharmaceuticals

• Sean Brynjelsen, Chief Executive Officer ans Director
• Paul Maier, Director
• Norbert Riedel, Chairman of the Board

Popular executive movements at Eton Pharmaceuticals

• Judith Matthews will join the company as Chief Financial Officer on Jun. 1, 2026  (posted on April 17 2026).
• Michael Lindquist has joined the company as Director, Supply Chain  (posted on April 17 2026).
• James Gruber, Chief Financial Officer, will leave the company on Jun. 1, 2026  (posted on April 17 2026).

Click here to view some more movements at Eton Pharmaceuticals

Create your alert
to follow the executive moves at Eton Pharmaceuticals.

Eton Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Eton Pharmaceuticals

• Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022 | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension) | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Announces Sale of Hospital Products | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Reports First Quarter 2022 Financial Results | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022 | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals and XGen Pharmaceuticals DJB Announce Commercial Launch of Rezipres® (ephedrine hydrochloride), a Ready-to-Use Formulation of Injectable Ephedrine (4.7 mg/mL) | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals to Report Fourth Quarter 2021 Financial Results on Wednesday, March 16, 2022 | Eton Pharmaceuticals, Inc.
• Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection | Eton Pharmaceuticals, Inc.
• View more press releases Close

Social media about Eton Pharmaceuticals

• Eton Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Eton Pharmaceuticals on LinkedIn, X (Twitter) & YouTube